SAWYER; Jason Scott
Patent Applications and Registrations
Patent applications and USPTO patent grants for SAWYER; Jason Scott.The latest application filed is for "use of 2-{4-[(4-{[1-cyclopropyl-3-tetrahydro-2h-pyran-4-yl)-1h-pyrazol-4yl- ]oxy} pyridine-2-yl)amino]pyridin-2-yl}propan-2-ol i".
Company Profile
1.49.45
- SAWYER; Jason Scott - Indianapolis IN
Patent Activity
| Patent | Date |
|---|---|
| USE OF 2-{4-[(4-{[1-CYCLOPROPYL-3-TETRAHYDRO-2H-PYRAN-4-yl)-1H-PYRAZOL-4yl- ]OXY} PYRIDINE-2-yl)AMINO]PYRIDIN-2-yl}PROPAN-2-OL I App 20190216786 - BENHADJI; Karim Adnane ; et al. | 2019-07-18 |
| Aminopyridyloxypyrazole compounds Grant 9,617,243 - McMillen , et al. April 11, 2 | 2017-04-11 |
| Aminopyridyloxypyrazole Compounds App 20160096823 - MCMILLEN; William T. ; et al. | 2016-04-07 |
| AKT inhibitors Grant 8,436,002 - Beight , et al. May 7, 2 | 2013-05-07 |
| Akt Inhibitors App 20120149684 - Beight; Douglas Wade ; et al. | 2012-06-14 |
| Triazolyl aminopyrimidine compounds Grant 8,114,872 - Crich , et al. February 14, 2 | 2012-02-14 |
| Triazolyl aminopyrimidine compounds Grant 8,063,035 - Crich , et al. November 22, 2 | 2011-11-22 |
| Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer Grant 8,063,212 - Brooks , et al. November 22, 2 | 2011-11-22 |
| Quinolinyl-pyrrolopyrazoles Grant 7,834,029 - Beight , et al. November 16, 2 | 2010-11-16 |
| Triazolyl Aminopyrimidine Compounds App 20100130466 - Brooks; Harold Burns ; et al. | 2010-05-27 |
| Triazolyl Aminopyrimidine Compounds App 20100087431 - Brooks; Harold Burns ; et al. | 2010-04-08 |
| Imidazolidinonyl Aminopyrimidine Compounds For The Treatment Of Cancer App 20100081641 - Brooks; Harold Burns ; et al. | 2010-04-01 |
| Mixed lineage kinase modulators Grant 7,511,065 - Goodson, Jr. , et al. March 31, 2 | 2009-03-31 |
| TGF-.beta. inhibitors Grant 7,511,056 - Diefenbacher , et al. March 31, 2 | 2009-03-31 |
| Tgf-Beta Inhibitors App 20080262004 - Diefenbacher; Clive Gideon ; et al. | 2008-10-23 |
| Compounds as pharmaceutical agents Grant 7,405,299 - Beight , et al. July 29, 2 | 2008-07-29 |
| Pyrazolopyridine derivatives as pharmaceutical agents Grant 7,365,066 - Beight , et al. April 29, 2 | 2008-04-29 |
| Quinolinyl-pyrrolopyrazoles App 20080027102 - Beight; Douglas Wade ; et al. | 2008-01-31 |
| Quinolinyl-pyrrolopyrazoles Grant 7,265,225 - Beight , et al. September 4, 2 | 2007-09-04 |
| Cyclopenta[b]indole derivatives as sPLA.sub.2 inhibitors Grant 7,160,909 - Kinnick , et al. January 9, 2 | 2007-01-09 |
| Aromatic amides Grant 7,129,245 - Beight , et al. October 31, 2 | 2006-10-31 |
| Cyclohept[b]indole derivatives Grant 7,109,231 - Kinnick , et al. September 19, 2 | 2006-09-19 |
| Pyrrole derivatives as pharmaceutical agents Grant 7,087,626 - Beight , et al. August 8, 2 | 2006-08-08 |
| Fused heterocyclic derivatives as phosphodiesterase inhibitors Grant 7,034,027 - Orme , et al. April 25, 2 | 2006-04-25 |
| Pyrazoloazepine compounds as pharmaceutical agents App 20060079680 - Sawyer; Jason Scott | 2006-04-13 |
| Novel compounds as pharmaceutical agents App 20060058295 - Beight; Douglas Wade ; et al. | 2006-03-16 |
| Quinolinyl-pyrrolopyrazoles App 20060040983 - Beight; Douglas Wade ; et al. | 2006-02-23 |
| sPLA.sub.2 inhibitors Grant 6,992,100 - Beight , et al. January 31, 2 | 2006-01-31 |
| Aromatic amides App 20050282862 - Beight, Douglas Wade ; et al. | 2005-12-22 |
| sPLA2 inhibitors Grant 6,974,831 - Beight , et al. December 13, 2 | 2005-12-13 |
| Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction Grant 6,962,918 - Orme , et al. November 8, 2 | 2005-11-08 |
| Condensed pyrazindione derivatives as PDE inhibitors Grant 6,960,587 - Orme , et al. November 1, 2 | 2005-11-01 |
| Novel pyrazolopyridine derivatives as pharmaceutical agents App 20050222197 - Beight, Douglas Wade ; et al. | 2005-10-06 |
| sPLA2 inhibitors Grant 6,930,123 - Beight , et al. August 16, 2 | 2005-08-16 |
| Antithrombotic agents Grant 6,924,296 - Beight , et al. August 2, 2 | 2005-08-02 |
| Spla2 inhibitors Grant 6,916,840 - Beight , et al. July 12, 2 | 2005-07-12 |
| Pyrazino[1',2':1,6]pyrido[3,4b]indole derivatives Grant 6,911,542 - Orme , et al. June 28, 2 | 2005-06-28 |
| Condensed pyrazindione derivatives Grant 6,903,099 - Orme , et al. June 7, 2 | 2005-06-07 |
| Indole derivatives as PDE5-inhibitors Grant 6,878,711 - Orme , et al. April 12, 2 | 2005-04-12 |
| Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1',2':1,6]pyrido[3,4b]-indole-1,4-dione Grant 6,872,721 - Orme , et al. March 29, 2 | 2005-03-29 |
| sPLA2 inhibitors Grant 6,872,743 - Beight , et al. March 29, 2 | 2005-03-29 |
| Condensed pyridoindole derivatives Grant 6,858,620 - Orme , et al. February 22, 2 | 2005-02-22 |
| Cyclopenta'b! indole derivatives as spla inhibitors App 20050026988 - Kinnick, Michael Dean ; et al. | 2005-02-03 |
| Condensed pyridoindole derivatives Grant 6,838,456 - Orme , et al. January 4, 2 | 2005-01-04 |
| Cyclic GMP-specific phosphodiesterase inhibitors Grant 6,825,197 - Orme , et al. November 30, 2 | 2004-11-30 |
| Cyclohept'b!indole derivatives as spla2 inhibitors App 20040198801 - Kinnick, Michael Dean ; et al. | 2004-10-07 |
| Heterocycle substituted diphenyl leukotriene antagonists App 20040198779 - Sawyer, Jason Scott ; et al. | 2004-10-07 |
| Heterocycle substituted diphenyl leukotriene antagonists Grant 6,797,723 - Sawyer , et al. September 28, 2 | 2004-09-28 |
| Antithrombotic amides Grant 6,780,878 - Beight , et al. August 24, 2 | 2004-08-24 |
| Aromatic amides Grant 6,759,414 - Beight , et al. July 6, 2 | 2004-07-06 |
| Novel spla2 inhibitors App 20040092543 - Beight, Douglas Wade ; et al. | 2004-05-13 |
| sPLA2 inhibitors Grant 6,730,694 - Beight , et al. May 4, 2 | 2004-05-04 |
| Chemical compounds App 20040082787 - Orme, Mark W ; et al. | 2004-04-29 |
| Novel spla2 inhibitors App 20040077704 - Beight, Douglas Wade ; et al. | 2004-04-22 |
| Antithrombotic amides Grant 6,716,855 - Beight , et al. April 6, 2 | 2004-04-06 |
| Antithrombotic amides Grant 6,716,839 - Beight , et al. April 6, 2 | 2004-04-06 |
| Novel spla2 inhibitors App 20040063941 - Beight, Douglas Wade ; et al. | 2004-04-01 |
| Novel spla2 inhibitors App 20040063967 - Beight, Douglas Wade ; et al. | 2004-04-01 |
| Substituted tricyclics Grant 6,713,645 - Bach , et al. March 30, 2 | 2004-03-30 |
| Spla2 inhibitors App 20040059130 - Beight, Douglas Wade ; et al. | 2004-03-25 |
| Antithrombotic amides Grant 6,710,057 - Beight , et al. March 23, 2 | 2004-03-23 |
| Chemical compounds App 20040038978 - Orme, Mark W. ; et al. | 2004-02-26 |
| Aromatic amides App 20040029874 - Beight, Douglas Wade ; et al. | 2004-02-12 |
| Heteroroaromatic amides as inhibitor of factor Xa Grant 6,689,780 - Beight , et al. February 10, 2 | 2004-02-10 |
| Antithrombotic agents App 20040010017 - Beight, Douglas Wade ; et al. | 2004-01-15 |
| Antithrombotic agents Grant 6,677,369 - Beight , et al. January 13, 2 | 2004-01-13 |
| Chemical compounds App 20030236263 - Orme, Mark W. ; et al. | 2003-12-25 |
| Indole derivatives as pde5-inhibitors App 20030229080 - Orme, Mark W ; et al. | 2003-12-11 |
| Chemical compounds App 20030225092 - Orme, Mark W. ; et al. | 2003-12-04 |
| Cyclic gmp-specific phosphodiesterase inhibitors App 20030225093 - Orme, Mark W ; et al. | 2003-12-04 |
| Chemical compounds App 20030225094 - Orme, Mark W ; et al. | 2003-12-04 |
| Antithrombotic amides App 20030212069 - Beight, Douglas Wade ; et al. | 2003-11-13 |
| Fused heterocyclic derivatives as phosphodiesterase inhibitors App 20030207867 - Orme, Mark W. ; et al. | 2003-11-06 |
| Chemical compounds App 20030207906 - Orme, Mark W. ; et al. | 2003-11-06 |
| Antithrombotic amides App 20030199504 - Beight, Douglas Wade ; et al. | 2003-10-23 |
| Antithrombotic amides App 20030199505 - Beight, Douglas Wade ; et al. | 2003-10-23 |
| Aromatic amides Grant 6,635,657 - Beight , et al. October 21, 2 | 2003-10-21 |
| Antithrombotic agents App 20030195223 - Beight, Douglas Wade ; et al. | 2003-10-16 |
| Antithrombotic amides App 20030191153 - Beight, Douglas Wade ; et al. | 2003-10-09 |
| Chemical compounds App 20030181457 - Orme, Mark W ; et al. | 2003-09-25 |
| Antithrombotic amides Grant 6,610,704 - Beight , et al. August 26, 2 | 2003-08-26 |
| Antithrombotic agents Grant 6,605,626 - Beight , et al. August 12, 2 | 2003-08-12 |
| Antithrombotic agents App 20030078431 - Beight, Douglas Wade ; et al. | 2003-04-24 |
| Antithrombotic agents App 20020173518 - Beight, Douglas Wade ; et al. | 2002-11-21 |
| Antithrombotic agents App 20020120007 - Beight, Douglas Wade ; et al. | 2002-08-29 |
| Antithrombotic agents Grant 6,417,200 - Beight , et al. July 9, 2 | 2002-07-09 |
| Antithrombotic agents App 20020072531 - Beight, Douglas Wade ; et al. | 2002-06-13 |
| Antithrombotic agents App 20020049234 - Beight, Douglas Wade ; et al. | 2002-04-25 |
| Antithrombotic agents Grant 6,372,759 - Beight , et al. April 16, 2 | 2002-04-16 |
| Methods for identifying and treating resistant tumors App 20020013370 - Sawyer, Jason Scott ; et al. | 2002-01-31 |
| Methods for identifying and treating resistant tumors App 20020010213 - Sawyer, Jason Scott ; et al. | 2002-01-24 |
| Antithrombotic agents Grant 6,313,122 - Beight , et al. November 6, 2 | 2001-11-06 |
| Substituted tricyclics Grant 6,177,440 - Bach , et al. January 23, 2 | 2001-01-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 